Difference spectrophotometric method for the determination of Fluphenazine hydrochloride in tablets using peroxomonosulfate by Blazheyevskiy, Mykola et al.
FRENCH-UKRAINIAN JOURNAL OF CHEMISTRY (2021, VOLUME 09, ISSUE 02)  
64 
 
Difference spectrophotometric method for the determination of Fluphenazine 
hydrochloride in tablets using peroxomonosulfate 
Mykola Ye. Blazheyevskiy a, Valeriy P. Morozb, Olena O. Mozgovaa 
a Department of Inorganic and Physical Chemistry of National University of Pharmacy, Pushkinska 
street, 53, Kharkiv, Ukraine 
b Department of Analytical Chemistry and Analytical Toxicology of National University of 
Pharmacy, Pushkinska street, 53, Kharkiv, Ukraine 
elena.mozgovaya25@gmail.com 
 
Keywords: spectrophotometric method, Fluphenazine hydrochloride, optical density, 
peroxomonosulfate. 
The oxidative derivatization method using potassium hydrogenperoxomonosulfate for the indirect 
spectrophotometric determination of Fluphenazine hydrochloride is presented. Potassium 
hydrogenperoxomonosulfate is introduced as a derivatizing agent for Fluphenazine hydrochloride, 
yielding the sulfoxide. This reaction product was successfully used for the spectrophotometric 
determination of the Fluphenazine hydrochloride. The UV spectroscopic detection of the sulfoxide 
proved to be a more robust and sensitive method. The elaborated method allowed the determination 
of Fluphenazine hydrochloride in the concentration range of 0.2-30 µg mL-1. The molar absorptivity 
at 349 nm is 5.6×103 (dm3cm-1mol-1). The limit of quantification, LOQ (10S) is 0.24 µg/mL. A new 
spectrophotometric technique was developed and the possibility of quantitative determination of 
Fluphenazine hydrochloride in tablets 5.0 mg was demonstrated. The present method is precise, 




Fluphenazine hydrochloride (FPh), 2-[4-
[3-(2-(trifluoromethyl)phenothiazine-10-
yl)propyl]piperazine-1-yl]ethanol 
dihydrochloride (Figure 1) belongs to the 
piperazine class of phenothiazines [1], and is a 
typical antipsychotic drug used for the treatment 
of psychoses such as schizophrenia, manic 
phases of bipolar disorder, agitation, and 
dementia [2]. In addition, as a serotonin 
antagonist, this agent may inhibit lymphocyte 
and myeloma cell proliferation [3]  
 
Figure 1. The molecular structure of Fluphenazine 
hydrochloride 
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Numerous analytical methods have been 
noticed in the literature for the determination of 
FPh, either in pure form or pharmaceutical 
preparations and biological fluids. These 
methods include spectrophotometry [4-5], 
spectrofluorimetry [6-8], voltammetry [9-11], 
high performance liquid chromatography 
(HPLC) [12-17], densitometric high 
performance thin layer chromatography 
(HPTLC) [18] capillary electrophoresis [19], and 
chemiluminescence [20].  
The British Pharmacopoeia (BPh) [21] 
recommended a non-aqueous potentiometric 
method for the determination of FPh using 
perchloric acid as a titrant; the LOQ was 6.3 mg 
mL-1. For analysis of its tablets, the British 
Pharmacopoeia (BPh) and the European 
Pharmacopoeia (Ph Eur) recommended a 
spectrophotometric method based on recording 
second-derivative ultraviolet absorption spectra 
of the working and reference solutions in the 
range 230 to 300 nm. For each solution, the 
amplitude was measured from the peak at about 
266 nm to the peak at about 258 nm [22]. 
The United States Pharmacopoeia (USP) 
on the other hand, described an HPLC method for 
the determination of FPh in pure form, 
Fluphenazine Hydrochloride Injection and 
Fluphenazine Hydrochloride Tablets using UV 
detection at 254 nm, where the LOQ was 2.4 µg 
mL-1 [23]. 
However, HPLC method involves 
sophisticated and expensive equipment or 
solvents and is time-consuming. Therefore, there 
is a need for an alternative substitute to the HPLC 
methods, and the method of derivatization 
difference spectrophotometry by virtue of its 
high sensitivity and selectivity can be a 
promising substitute [24, 25]. 
The application of the method of 
derivatization spectrophotometrу with the use of 
potassium hydrogenperoxomonosulfate (oxone) 
as a derivatizing reagent is currently very 
promising. The light absorption of the oxidation 
product by this reagent, the corresponding FPh 
sulfoxide (Figure 2), can be successfully used to 
develop a relatively simple method for the 
quantitative determination of FPh in 
pharmaceuticals, in particular in 5 mg tablets. 
 
Figure 2. Scheme of FPh oxidation by oxone 
In difference spectroscopy, a component in 
a mixture is analyzed by carrying out a reaction 
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which is selective for the analyte, this chemical 
transformation, an oxidation for example, 
inducing a wavelength shift. 
Excipients do not undergo appreciable 
shifts whereas FPh does. Figure shows the 
spectrum of the extract from tablets in 0.001 M 
H2SO4. In fact, there is relatively minor 
background noise at the wavelength used for the 
determination of FPh but by using the sample in 
H2SO4 in place of a blank in the reference cell, 
one can be sure that background noise from 
excipients will be eliminated. 
Figure 3 shows the difference spectra of 
the tablets extract in 0.001 M H2SO4 in the 
reference cell and the tablets extract in 0.001 M 
H2SO4 with oxone in the sample cell. The 
absorbance at 349 nm is thus wholly due to FPh.  
 
Figure 3. Electronic spectra of FPh hydrochloride (1) and 
FPh sulfoxide (2). с(FPh) =2.610-5 mol L-1; с(FPh 
sulfoxide) = 2.610-5 mol L-1; с (Н2SO4) =1.010-3 mol L-1 
 
The problem remains of how to quantify 
the analyte in such a sample. This can be readily 
carried out using through the addition of a known 
amount of FPh as a standard and comparison of 
the absorbance of the original sample extract 
with the absorbance of the spiked sample. 
 
Experimental part 
Materials and methods 
As an analytical reagent, potassium 
hydrogenperoxomonosulfate (oxone) in the form 
of a stable triple salt Oxone®, monopersulfate 
(2КНSO5·КНSO4·К2SO4) (SIGMA-ALDRICH, 
CAS: 70693-62-8, the content of active oxygen 
4.5 %) was used. 
Oxone solution. 600 mg of oxone was 
dissolved in a 100 mL volumetric flask by twice 
distilled water and mixed thoroughly. The exact 
content of potassium hydrogen 
peroxymonosulfate in the solution was 
monitored by iodometric titration [24, 26]. 
Fluphenazine dihydrochloride (FPh) 
(Sigma-Aldrich, qualification: Pharmaceutical 
Primary Standard). Synonym: 4-[3-[2-
(Trifluoromethyl)-10H-phenothiazin-10-
yl]propyl]-1-piperazineethanol dihydrochloride, 
CAS number 146-56-5, C22H26F3N3OS∙2HCl, 
molecular weight 510.44 g mol-1. 
It is a chemical reference substance (CRS 
Pharmacopoeial standard (EPh), purity not less 
than 99.5 % (titer)). All other reagents were "pure 
for analysis" or "chemically pure" and used 
without further purification. 
Fluphenazine working standard solution, 
0.10 mg mL-1, was prepared by volume-weight 
method. A sample of the preparation with a 
known content of the main substance containing 
10.0 mg of FPh in terms of FPh hydrochloride, 
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The object of study was tablets 
Fluphenazine (HCl) 5mg, production Mediphar 
Laboratories (Dbayeh, Lebanon), batch number 
8273. The average weight of the tablet (n=15) 
was 0.3177 g. Stated content in the tablets: 
Fluphenazine Hydrochloride 5.0 mg and inactive 
ingredients: hydroxypropyl methylcellulose, 
lactose monohydrate; polyethylene glycol; 
polysorbate 80, povidone, stearic acid, and 
titanium dioxide 
Procedure for obtaining results of the 
calibration graph. Using a pipette, different 
volumes of Fluphenazine working standard 
solution (1.00–15.00 mL) were taken and 
transferred to a 50 mL volumetric flask. 0.5 mL 
of 0.1 M sulfuric acid solution, 1.0 mL of 2×10-2 
mol L-1 oxone solution are added thereto and this 
solution was diluted to the volume with twice 
distilled water, cork and mix thoroughly for 5 
minutes. Fill the cuvette with the resulting 
solution and measure the light absorption on a 
spectrophotometer at a wavelength of 349 nm. 
The graph was positioned in the following 
coordinates: the absorbance (A) on the ordinate 
axis and corresponding concentration of FPh, C 
in µg mL-1 on the abscissa axis (Fig. 4). The 
graph equation coefficients have been calculated 
by least square method. 
Procedure for determining the content of 
Fluphenazine in tablets of 5 mg (by the addition 
method). Analysis was carried out by difference 
spectrophotometry. A one-point standard 
calibration for the determination of FPh in a 
standard stock solution was used. 
Test solution was prepared by dissolving 
0.64 g (accurate weight) of powdered tablets (5 
mg each), which corresponds to the average 
weight of two tablets, with 1.0 mL of 0.1 M 
sulfuric acid solution and 20-30 mL of water. 
Mix thoroughly on a shaker for 30 minutes, filter 
through a "blue tape" filter, rinse the residue 
thoroughly on the filter with twice distilled water 
and, combining the filtrates, transfer the solution 
quantitatively into a 100 mL volumetric flask. 
The solution was diluted to the volume with 
twice distilled water and mixed thoroughly. 
Using a pipette, 10.0 mL of the resulting solution 
is taken and transferred to a 50 mL volumetric 
flask, 0.5 mL of 0.1 M sulfuric acid solution, 1.0 
mL of 2×10-2 mol L-1 oxone solution are added 
thereto and this solution was diluted to the 
volume with twice distilled water, cork and mix 
thoroughly for 5 minutes. Fill the cuvette with the 
resulting solution and measure the light 
absorption on a spectrophotometer at a 
wavelength of 349 nm. Readings were taken at 
349 nm of the sample solution without standard 
addition versus reference solution 1.  
The reagent solution, which contained the 
solvent in which the analyte was solubilized and 
the reagent added to the sample prior to 
measurement, showed no absorbance at 349 nm.  
Similar procedures are performed with a 
solution with the addition of a working standard 
sample. Using a pipette, 10.0 mL of the resulting 
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solution is taken and transferred to a 50 mL 
volumetric flask, 5.0 mL of standard solution of 
FPh, 0.5 mL of 0.1 M sulfuric acid solution, 1.0 
mL of 2×10-2 mol l-1 oxone solution are added 
thereto and this solution was diluted to the 
volume with twice distilled water, cork and mix 
thoroughly for 5 minutes. Fill the cuvette with the 
resulting solution and measure the light 
absorption on a spectrophotometer at a 
wavelength of 349 nm. Readings were taken at 
349 nm of the sample solutions with standard 
addition versus reference solution 2. 
The content of fluphenazine in terms of 
fluphenazine dihydrochloride in mg in one tablet 
is calculated by the formula: 
Х = (Сst ×Aх × k × V× m) / [(Aх+st – Aх) × ms] 
where Ах – optical density in the experiment with the 
test solution of tablets; 
Ах+st – optical density in the experiment with the 
investigated solution of tablets and FPh standard 
solution; 
Cst – the concentration of fluphenazine 
hydrochloride in the cuvette in the experiment 
with the test solution of tablets and FPh standard 
solution, mg mL-1; 
ms – weight of a sample of tablet powder, g; 
m – the average weight of the tablet, g; 
V – volumetric flask volume; 
k – dilution factor. 
Results and discussions 
The linear dependence of the absorbance is 
observed in the FPh concentration range 1-30 µg 
mL-1, the calibration curve equation was 
А = (1.12±0.005)10-2C (r = 0.999) (Figure 4). 
Analytical characteristics of the calibration 
graph for the quantification of FPh hydrochloride as 
the corresponding sulfoxide are given in Table 1. 
 
Figure 4. Calibration graph for the quantification of FPh 
hydrochloride as the corresponding sulfoxide. с(Н2SO4) = 
1.010-3 mol L-1 
 
Table 1. Analytical characteristics of the calibration 
graph (y=a+bx) for the quantification of FPh 
hydrochloride as the corresponding sulfoxide 
Characteristics Parameters 
Concentration range 
 (µg mL-1) 
0.2-30 
Correlation coefficient (r) 0.999 
Linear regression 
equation 
y = 0.0112x – 
0.0002 
Slope (b±Δb) 0.0112±0.00005 
Intercept (a±Δa) –0.0002±0.0008 
S.D. of slope (Sb) 0.00002 
S.D. of intercept (Sa) 0.0003 
LOD (3S) (µg mL-1) 0.071 
LOQ (10S) (µg mL-1) 0.238 
 
The molar absorptivity (dm3cm-1mol-1) at 
349 nm is 5622.7±32.6; LOQ = 0.24 µg mL-1. 
The results of the quantitative 
determination of FPh hydrochloride in 5 mg 
tablets are given in Table 2. Fluphenazine tablets 
contain from 90.0 % to 110.0 % of the specified 
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amount of fluphenazine hydrochloride 
(C22H26F3N3OS · 2HCl). 
Table 2. Results of the quantitative determination of 








0.64000 g tablets 
powder 
Fluphenazine 
hydrochloride 5 mg, 
Mediphar 
Laboratories 






х = 4.95 
(R=100.40%)* 
S = 0.0676 
Δх = 0.0841 
RSD = 1.37 % 
δ* =+0.41 % 
Notes: * The calculation is based on the average 
content found by the method of USP 39 (4.93 mg / tablet - 
98.60 ± 10% (μ). δ = (х-μ) 100% / μ 
 
Precision and accuracy 
The levels of precision and accuracy of the 
measurement method were confirmed by 
calculation of the relative standard deviation 
(%RSD) and percentage recovery (%R) using 
five replicate measurements of a drug sample; the 
trueness of the measurement method was 
investigated by comparing the accepted reference 
value (according to the certificate of analysis) 
with the results given by the measurement 
method. In general, good levels of precision were 
obtained for API with perfect value of 1.37% 
RSD, as shown in Table 2. The results obtained 
for the API analysis using the differential 
spectrophotometric method were highly 
comparable to the certified value. Analytical 
recovery value is 100.40 % for API determined, 
as reported in Table 2. 
In conclusion, the proposed method 
provided a sensitive, specific and inexpensive 
analytical procedure for Fluphenazine 
hydrochloride. It can be applied for quality 
control testing and drug stability monitoring. 
This subject is now under investigation. 
 
Conclusions 
For the first time, a procedure for the 
indirect spectrophotometric determination of 
Fluphenazine hydrochloride as its S-oxide 
obtained by reaction with potassium 
hydroperoxomonosulfate was proposed for use 
in pharmaceutical analysis. The proposed 
spectrophotometric method for the determination 
of Fluphenazine hydrochloride is simple, 
reliable, sufficiently sensitive and accurate, is 
faster and does not require expensive and 
relatively toxic solvents needed for HPLC 
procedures. A new spectrophotometric technique 
was developed and the possibility of quantitative 
determination of Fluphenazine hydrochloride in 
tablets 5.0 mg was demonstrated. The present 
method is precise, accurate and excipients did not 
interfere. RSD for Fluphenazine hydrochloride 
5.0 mg tablets was 1.37 %.   
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